High-Risk Veteran Initiative
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Sep 9, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The High-Risk Veteran Initiative, also known as the RIVET Program, is a clinical trial aimed at improving the health care for veterans who are at a high risk of needing hospitalization due to multiple health conditions. The program focuses on using proven methods to help primary care teams provide better, more personalized care to these veterans. By doing this, the RIVET Program hopes to reduce unnecessary hospital visits and enhance the overall health of participants.
To be eligible for this study, participants must be veterans receiving care at any VA site across the country. There are no restrictions based on age or gender, as long as they are part of the VA system. If you join this trial, you can expect to be involved in a program that aims to improve health care practices while receiving support and training that could benefit both you and future veterans. Overall, the goal is to make sure that veterans get the best care possible, tailored to their unique health needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any VA site nationwide
- Exclusion Criteria:
- • Not a VA site nationwide
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Sepulveda, California, United States
Pittsburgh, Pennsylvania, United States
Seattle, Washington, United States
Patients applied
Trial Officials
Evelyn T Chang, MD MSHS
Principal Investigator
VA Greater Los Angeles Healthcare System, Sepulveda, CA
Susan E Stockdale, PhD MA
Principal Investigator
VA Greater Los Angeles Healthcare System, Sepulveda, CA
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials